HeXun Biosciences Co., Ltd. (6986.TWO)

TWD 76.7

(-1.29%)

Annual Cash Flows

(In TWD)
Breakdown 2023 2022 2021
Operating Cash Flow 43.09 Million 11.22 Million -35.5 Million
Net Income 33.48 Million -5.18 Million -42.98 Million
Depreciation & Amortization 20.3 Million 14.71 Million 11.9 Million
Deferred income taxes - - -
Stock-based compensation - 303 Thousand -
Change in working capital -10.67 Million 1.46 Million -4.69 Million
Other non-cash items -934 Thousand 1.18 Million 2.01 Million
Investing Cash Flow -25.27 Million -79.04 Million -26.94 Million
Investments in PPE -22.81 Million -1.22 Million -
Acquisitions - - -
Investment purchases - -72 Million -
Sales/Maturities of investments - - -
Other Investing Activities -2.46 Million -5.95 Million -35.78 Million
Financing Cash Flow 120.11 Million 102.53 Million 75.78 Million
Debt repayment -2.15 Million -392 Thousand -
Dividends payments - - -
Common Stock Repurchased - - -
Common Stock Issuance 125 Million 105 Million 78 Million
Other Financing Activities -2.72 Million - -200 Thousand
Accounts receivables -17.3 Million - -
Accounts payables - - -
Inventory -4.59 Million - -
Other working capital 11.22 Million - -
Cash at beginning of period 119.74 Million 85.02 Million 71.68 Million
Cash at end of period 257.67 Million 119.74 Million 85.02 Million
Capital Expenditure -22.81 Million -1.22 Million -
Effect of forex changes on cash - - -
Net cash flow / Change in cash 137.92 Million 34.71 Million 13.34 Million
Free Cash Flow 20.27 Million 10 Million -35.5 Million

Cash Flow Charts